Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The beta-lactamase problem: new therapeutic options

G C Schito1, A Pesce, E A Debbia

  • 1Institute of Microbiology, University of Genoa, Medical School, Italy.

Journal of Chemotherapy (Florence, Italy)
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Experimental Limit on the Permanent Electric Dipole Moment of the Deuteron.

Physical review letters·2026
Same author

Evaluation of persistence of Candidozyma auris colonization.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Milk metabolomic alterations correlated with intramammary infection in dairy cows: From healthy status to clinical mastitis.

Journal of dairy science·2026
Same author

The ghost dead: ethical and medico legal analysis on the Mediterranean tragedies.

La Clinica terapeutica·2024
Same author

Percutaneous ablation in perivascular-HCC: impact of liver parenchyma and characteristics of vascular structures on the outcomes.

Clinical radiology·2024
Same author

Furcate cord insertion: under-reported but likely relevant.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023

Cefetamet pivoxil shows superior in vitro activity against common bacterial pathogens compared to other antibiotics. This broad-spectrum cephalosporin is a promising option for empiric therapy of community-acquired respiratory and urinary infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Bacterial resistance to beta-lactam antibiotics, mediated by beta-lactamases, is a growing global health concern.
  • New beta-lactam compounds with enhanced stability against beta-lactamases are crucial for effective treatment.
  • Oral third-generation cephalosporins represent a significant advancement in combating antibiotic resistance.

Purpose of the Study:

  • To evaluate the in vitro activity of cefetamet pivoxil against a large collection of bacterial isolates.
  • To compare the efficacy of cefetamet pivoxil with other commonly used antibiotics for community-acquired infections.

Main Methods:

  • A survey involving 4191 bacterial isolates was conducted in Italy.
  • In vitro susceptibility testing was performed for cefetamet pivoxil and several other antibiotics.

Related Experiment Videos

  • Comparative analysis of eradication rates was conducted.

    • Main Results:

    • Cefetamet pivoxil demonstrated the highest in vitro activity among all tested agents.
    • Cefixime showed the second-highest activity, followed by other comparative antibiotics.
    • Resistance rates to cefetamet were low in prevalent community-acquired pathogens.

    Conclusions:

    • Cefetamet pivoxil exhibits potent in vitro activity and is a strong candidate for empiric therapy of respiratory and urinary tract infections.
    • Its broad coverage of gram-negative and gram-positive pathogens makes it effective against common community-acquired infections.
    • Low resistance prevalence suggests cefetamet pivoxil can minimize therapeutic failures in empiric treatment strategies.